Five Things For Pharmacists To Know About The Treatment Of Mycobacterium Tuberculosis
ID Stewardship
JUNE 19, 2025
Despite advancements in treatment, certain patients may exhibit delayed responses, have drug-resistant TB, be at risk for drug-drug interactions, or have comorbid conditions that considerably complicate clinical management. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. Acta Ophthalmol.
Let's personalize your content